The primary objective of this study is to analyse the effects of DNA-PK inhibitor, NU7441, on the global gene expressions in breast cancer cells and identified the cellular functions and pathways regulated by NU7441 in breast cancer cells. The gene discussed is PRKDC; the disease is breast carcinoma.